Clinical Trial Update: Pharmacokinetic Profile and Pharmacodynamic Characteristics of a Furosemide High Dosage Formulation in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis [Phase 1]

View source ↗

Summary

This Phase 1 study reports the pharmacokinetic and pharmacodynamic characteristics of a high-dose furosemide formulation in patients with chronic kidney disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Lasix (furosemide)

Snippet

Sponsor: Sanofi | Conditions: Renal Failure | Phase 1 | Status: COMPLETED